Vestor Capital LLC Sells 29,300 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Vestor Capital LLC reduced its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 64.6% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 16,062 shares of the healthcare conglomerate’s stock after selling 29,300 shares during the quarter. Vestor Capital LLC’s holdings in UnitedHealth Group were worth $9,391,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also recently made changes to their positions in UNH. Vanguard Group Inc. raised its holdings in shares of UnitedHealth Group by 0.6% in the 1st quarter. Vanguard Group Inc. now owns 84,405,255 shares of the healthcare conglomerate’s stock valued at $41,755,280,000 after purchasing an additional 544,740 shares in the last quarter. Price T Rowe Associates Inc. MD lifted its holdings in UnitedHealth Group by 0.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,062,928 shares of the healthcare conglomerate’s stock worth $12,893,331,000 after buying an additional 94,641 shares during the period. Bank of New York Mellon Corp increased its holdings in shares of UnitedHealth Group by 0.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 8,039,601 shares of the healthcare conglomerate’s stock valued at $4,094,247,000 after acquiring an additional 35,533 shares during the period. International Assets Investment Management LLC lifted its stake in shares of UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares during the last quarter. Finally, Dimensional Fund Advisors LP grew its stake in UnitedHealth Group by 30.0% in the second quarter. Dimensional Fund Advisors LP now owns 3,816,254 shares of the healthcare conglomerate’s stock valued at $1,942,956,000 after purchasing an additional 880,183 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $566.00 on Monday. The company has a quick ratio of 0.88, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $608.63. The business has a 50-day moving average price of $581.96 and a 200 day moving average price of $542.45. The firm has a market cap of $522.66 billion, a PE ratio of 36.97, a P/E/G ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter last year, the company earned $6.56 EPS. Sell-side analysts predict that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were given a $2.10 dividend. The ex-dividend date was Monday, September 16th. This represents a $8.40 annualized dividend and a dividend yield of 1.48%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on UNH shares. Jefferies Financial Group raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $481.00 to $647.00 in a research report on Wednesday, July 17th. Truist Financial reiterated a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Cantor Fitzgerald upped their target price on UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research report on Wednesday, October 16th. Wells Fargo & Company boosted their price target on UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Finally, Stephens dropped their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.